Commonwealth Diagnostics International, Inc.
39 Norman Street
Salem
Massachusetts
01970
United States
Tel: 888-258-5966
Fax: 888-258-5973
Website: http://commdx.com/
Email: info@commdx.com
About Commonwealth Diagnostics International, Inc.
Commonwealth Diagnostics is an international diagnostic service provider specializing in cutting-edge diagnostic products that assist physicians and patients with the diagnosis of some of the common sources of digestive distress and functional gastrointestinal disorders.YEAR FOUNDED:
2015
LEADERSHIP:
Executive Chairman: Brian J. Strasnick, PhD, JD
President & CEO: Craig S. Strasnick
EVP, Chief Legal Officer: Gray W. Rifkin
SVP, Internal Operations: Matt Pressman
SVP, International Operations: Federico Moschini
SVP, Commercial: Craig “CY” Yarwood
Executive Director, Project Planning & Development: Lisa Traficante Richard
VP, Human Resources: Alexandra Connors
SERVICES
Please click here for Commonwealth Diagnostics' services.
6 articles about Commonwealth Diagnostics International, Inc.
-
Commonwealth Diagnostics International, Inc.'s IBSchek® Granted PLA Code from AMA; Company to Now Accept Insurance, Providing More Patients At-Home Access
2/3/2021
Maximum out-of-pocket cost for first clinically validated IBS blood test also to be reduced, making it the most affordable IBS diagnostic test on the market
-
Commonwealth Diagnostics International Re-Launches IBSchek™ at Digestive Disease Week® (DDW) June 2018
5/31/2018
Commonwealth Diagnostics International (CDI), Inc. announced the commercial re-launch of IBSchek™.
-
CDI Receives MDEL in Canada for Non-Invasive Diagnostic Breath Tests for Patients with Small Intestinal Bacterial Overgrowth and Other Functional Gastrointestinal Disorders
4/24/2018
Commonwealth Diagnostics International, Inc. (CDI) announces its entry into the Canadian healthcare market.
-
Commonwealth Diagnostics International, Inc. Teams up With PGA Golfer Rob Oppenheim to Drive Awareness of Irritable Bowel Syndrome (IBS) and Small Intestinal Bacterial Overgrowth (SIBO)
1/30/2018
CDI and Oppenheim have teamed up to drive awareness around irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO), two of the leading causes of digestive distress affecting tens of millions of people in the United States and around the world.
-
Commonwealth Diagnostics Announces U.S. Launch And New Global Developments
8/31/2017
-
Commonwealth Diagnostics Presents Evidence To Support Improved Testing Methods To Facilitate Diagnosis Of Irritable Bowel Syndrome
5/10/2017